United States · FDA National Drug Code directory
Lacosamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-318_0267a67e-d492-480b-a688-e2cec27142a6
- Product NDC
- 69315-318
- Form
- SOLUTION
- Composition / generic term
- Lacosamide
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230206
- Source listing expiry
- 20261231
Source-listed ingredients
- LACOSAMIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 200 mL in 1 BOTTLE, PLASTIC (69315-318-20) · 69315-318-20
- 465 mL in 1 BOTTLE, PLASTIC (69315-318-46) · 69315-318-46
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →